Intended for healthcare professionals

  1. Research
  2. Changes in risk...
  3. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland
Papers

Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland

BMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6946.23 (Published 02 July 1994) Cite this as: BMJ 1994;309:23

Related articles

See more

Cited by...

  • Potential benefits of healthy food and lifestyle policies for reducing coronary heart disease mortality in Turkish adults by 2025: a modelling study
  • Resource Effective Strategies to Prevent and Treat Cardiovascular Disease
  • Quantifying Options for Reducing Coronary Heart Disease Mortality By 2020
  • Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study
  • Increase in physical activity and cardiometabolic risk profile change during lifestyle intervention in primary healthcare: 1-year follow-up study among individuals at high risk for type 2 diabetes
  • Lifestyle Intervention for Prevention of Type 2 Diabetes in Primary Health Care: One-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D)
  • Ten-year change in blood pressure levels and prevalence of hypertension in urban and rural Cameroon
  • Differences in Aneurysm and Patient Characteristics Between Cohorts of Finnish and Dutch Patients With Subarachnoid Hemorrhage: Time Trends Between 1986 and 2005
  • Ischaemic heart disease in Africa
  • Changes in traditional risk factors no longer explain time trends in cardiovascular mortality and its socioeconomic differences
  • Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000.
  • Contribution of regulatory and structural variations in APOE to predicting dyslipidemia
  • First myocardial infarction in a Dutch general practice population: trends in incidence from 1975-2003
  • Prevalence of the Metabolic Syndrome and Its Components: Findings from a Finnish general population sample and the Diabetes Prevention Study cohort
  • Geochemistry of ground water and the incidence of acute myocardial infarction in Finland
  • Predictive Properties of Impaired Glucose Tolerance for Cardiovascular Risk Are Not Explained by the Development of Overt Diabetes During Follow-Up
  • Missing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart disease
  • Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels
  • The Diabetes Risk Score: A practical tool to predict type 2 diabetes risk
  • The case of the missing data
  • Global Burden of Cardiovascular Diseases: Part II: Variations in Cardiovascular Disease by Specific Ethnic Groups and Geographic Regions and Prevention Strategies
  • Change in male and female life expectancy by social class: decomposition by age and cause of death in Finland 1971-95
  • Lifestyle measures to tackle atherosclerotic disease
  • Regional differences in the incidence of rheumatoid arthritis in Finland in 1995
  • Explanation for the Decline in Coronary Heart Disease Mortality Rates in Auckland, New Zealand, Between 1982 and 1993
  • Two-Year Changes in Blood Pressure and Subsequent Risk of Cardiovascular Disease in Men
  • Relationship of Socioeconomic Status to the Incidence and Prehospital, 28-Day, and 1-Year Mortality Rates of Acute Coronary Events in the FINMONICA Myocardial Infarction Register Study
  • Age-Dependent Association of Apolipoprotein E Genotype With Coronary and Aortic Atherosclerosis in Middle-Aged Men : An Autopsy Study
  • Cardiovascular disease in the Netherlands, 1975 to 1995: decline in mortality, but increasing numbers of patients with chronic conditions
  • Relationship of Therapeutic Improvements and 28-Day Case Fatality in Patients Hospitalized With Acute Myocardial Infarction Between 1978 and 1993 in the REGICOR Study, Gerona, Spain
  • Preventing ischaemic heart disease in one general practice: from one patient, through clinical audit, needs assessment, and commissioning into quality improvement • Commentary: Clinical and economic perspectives have to be integrated when selecting priorities for intervention
  • Cholesterol: how low is low enough?
  • Serum Cholesterol Distribution and Coronary Heart Disease Risk : Observations and Predictions Among Middle-aged Population in Eastern Finland
  • Approach to maintaining comparability of biochemical data during long-term clinical trials
  • Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease
  • Effect of socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community coronary event register
  • Decline of Coronary Heart Disease Mortality in Finland During 1983 to 1992: Roles of Incidence, Recurrence, and Case-Fatality: The FINMONICA MI Register Study
  • Cardiovascular Disease Epidemiology : A Journey From the Past Into the Future
  • Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland?
  • Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants
  • The limits to health promotion
  • The MONICA project comes of age
Back to top